Vitamin D Supplementation Could Reduce Migraine Headache Attacks
Researchers found that vitamin D supplementation could reduce headache attacks per month, headache days per month.
Pain Information Center
Duloxetine Does Not Alleviate Pain in Chronic Osteoarthritis
No differences seen in WOMAC pain at 3 or 12 months with duloxetine added to usual care, or in subgroup with symptoms of centralized pain.
Opioid-Sparing Effects Comparable Between Oral and IV Acetaminophen After Pediatric Tonsillectomy, Adenoidectomy
Researchers compared opioid-sparing effects between intravenous acetaminophen and oral acetaminophen in pediatric patients undergoing tonsillectomy and adenoidectomy.
PRP Injections No Better Than Placebo for Knee Osteoarthritis
Platelet-rich plasma injections did not significantly improve knee osteoarthritis pain symptoms or joint structure compared with placebo injections in a randomized controlled trial.
Pilates, McKenzie Therapy, and Functional Restoration More Effective Than Others in Reducing Chronic Low Back Pain
Study authors conducted a systematic review and meta-analysis to determine the effect of different exercise treatments on pain intensity in adults with chronic low back pain.
FDA Approves Virtual Reality System to Treat Chronic Back Pain
The FDA reports that EaseVRx uses the principles of cognitive behavioral therapy (CBT) and other behavioral therapy techniques to reduce pain and pain interferences.
Top October 2021 FDA Approvals
The October approvals include treatments for acute pain, opioid overdose, dry eye disease, and COVID-19 vaccine for children 5 to 11 years of age.
New Studies Point to Bidirectional Pathways Between Migraine and RA
A possible bidirectional association between migraine and rheumatoid arthritis (RA) is investigated.
Pain Management in Gout – A Video Interview With Lawrence Edwards, MD
Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Psychological Treatment Provides Pain Relief for Chronic Back Pain
Sixty-six percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20% in placebo group.
Migraine Management: How to Treat Patients With Vascular Disease
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there is no substantial evidence that they directly increase the risk for vascular events.
Top August & September 2021 FDA Approvals
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
Guideline: Evidence-Based Best Practices for the Management of Cancer-Related Pain
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
Trudhesa Nasal Spray Approved for Acute Treatment of Migraine
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
AHA Presidential Statement: The Link Between Opioid Use, CVD, and Stroke
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
Sleep Disorders Highly Prevalent in Children With Migraine
Higher Children’s Sleep Habits Questionnaire total score correlated with higher frequency of severe attacks, lower drug efficacy.
Are Epidural Steroid Injections Effective for Lumbosacral Radicular Syndrome?
The researchers performed a systematic review and meta-analyses to determine if epidural steroid injections result in clinically meaningful improvement in lumbosacral radicular syndrome.
Exploring Aspirin for the Treatment and Prevention of Migraines
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
Study Compares Remote Electrical Neuromodulation to Migraine Meds in Adolescents
Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.
Pain Management Education for APRNs Is Still Lacking
The majority of APRNs report low levels of preparedness in caring for patients with basic chronic or acute pain management needs in their first year of practice.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Pain Management Information Center
Loading... 
Loading...